Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN108689866A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108689866A reveals a safer synthetic route for (R)-3-amino butanols. Achieve high purity and yield with reduced operational risks for HIV drug intermediates.